No Data
Ping An Securities: The long-term outlook for innovative drugs is positive driven by three main factors: BD, commercialization, and policy.
Ping An Securities suggests paying attention to: 1) leading innovative drug companies with a rich pipeline; 2) companies with high potential single innovative drugs that are expected to be repriced; 3) companies that are Bullish on leading technology platform layouts.
Market quick view | All three major indices fell, with the Hang Seng Index down 0.64%; meanwhile, photovoltaic CECEP Solar Energy and biotechnology stocks rose against the trend, with XINYI ENERGY and REMEGEN both up about 15%.
Network Technology stocks generally fell, Bilibili-W rose by 5.31%, SenseTime-W rose by 2.72%; Photovoltaic Power stocks strengthened, XINYI ENERGY rose by 15.00%, TRIUMPH NEW EN rose by 8.39%; Semiconductor stocks performed well, IngDan rose by 5.03%, HUA HONG SEMI rose by 4.70%.
Hong Kong Stock Midday Review | The three major Indexes all declined, the Hang Seng Index fell by 0.62%; biotechnology and stablecoin Concept stocks rose against the trend, REMEGEN rose nearly 15%, and GUOTAI JUNAN I rose nearly 21%.
Network Technology stocks weakened, Bilibili-W rose by 5.31%, XIAOMI-W fell by 1.20%; Apple Concept stocks generally fell, AAC TECH dropped by 4.48%, SUNNY OPTICAL declined by 2.97%; Biotechnology stocks all rose, REMEGEN increased by 14.93%, AKESO grew by 8.20%.
BOCOM INTL reports that in recent months, southbound capital has primarily focused on the Medical and Financial Sectors, indicating an emphasis on the value of high-yield defensive investments.
BOCOM INTL published a report indicating that the Hong Kong stock market performed remarkably in the first half of this year, with the Hang Seng Index and Hang Seng TECH Index recording semi-annual returns of 20% and 18.7% respectively, ranking among the top global major stock indices. Although April's "reciprocal tariffs" temporarily triggered a global stock index pullback, as tariff risks gradually eased, the risk premium falling drove a comprehensive rebound in Hong Kong stocks. By the end of June, the Hang Seng Index was close to its peak for the year, primarily driven by the decline in risk premium, while contributions from risk-free rates and fundamental earnings improvement were relatively limited. Currently, the Hong Kong stocks are in a favorable window period benefiting from multiple bullish factors: the marginal convergence of external disturbances for the market.
BeOne Medicines Ltd. Announces Grant of Restricted Share Units
BEIGENE (06160.HK) granted restricted stock units.
Gelonghui, on July 3, announced that BEIGENE (06160.HK) issued a notice that on June 30, 2025, the Board of Directors' Compensation Committee granted a total of 43,839 American Depositary Shares restricted stock units to 216 grantees according to the terms of the 2016 Options and Incentive Plan. These restricted stock units are equivalent to 569,907 shares, accounting for approximately 0.04% of the total number of shares issued by the company on the date of this announcement.